These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7198475)

  • 1. Tolfenamic acid. Detection and structure of urinary metabolites.
    Pedersen SB; Alhede B; Buchardt O; Møller J; Bock K
    Arzneimittelforschung; 1981; 31(11):1944-8. PubMed ID: 7198475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and 1H NMR spectroscopic characterization of phase II metabolites of tolfenamic acid.
    Sidelmann UG; Christiansen E; Krogh L; Cornett C; Tjørnelund J; Hansen SH
    Drug Metab Dispos; 1997 Jun; 25(6):725-31. PubMed ID: 9193874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical studies of drug-protein complexes. 3. Interaction of flufenamic acid and other N-arylanthranilates with serum albumin.
    Chignell CF
    Mol Pharmacol; 1969 Sep; 5(5):455-62. PubMed ID: 5823761
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition.
    Glazko AJ
    Ann Phys Med; 1966; Suppl():23-36. PubMed ID: 4979052
    [No Abstract]   [Full Text] [Related]  

  • 5. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
    Gaganis P; Miners JO; Knights KM
    Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ionized fluorine in the plasma and urine of subjects treated with organofluorine drugs prescribed in rheumatology].
    Boiteau HL; Prost A; Rossel-Renac F; Audran M; Hamelin JP; Carlier N
    Rev Rhum Mal Osteoartic; 1979 Feb; 46(2):123-32. PubMed ID: 34870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On various derivatives of mefenamic and flufenamic acids].
    Spanò R; Marri R
    Boll Chim Farm; 1968 Aug; 107(8):512-5. PubMed ID: 5721222
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of metoclopramide on the absorption of tolfenamic acid.
    Tokola RA; Anttila VJ; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):465-8. PubMed ID: 7141754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tolfenamic acid on the metabolism of the main connective tissue components in rats.
    Krajícková J; Pesáková V; Adam M; Senius KE
    Arzneimittelforschung; 1987 Feb; 37(2):177-80. PubMed ID: 3495276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etofenamate fatty acid asters. An example of a new route of drug metabolism.
    Dell HD; Fielder J; Kamp R; Gau W; Kurz J; Weber B; Wuensche C
    Drug Metab Dispos; 1982; 10(1):55-60. PubMed ID: 6124384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analytical reactions of mefenamic and flufenamic acids].
    Devaux G; Mesnard P; Brisson AM
    Ann Pharm Fr; 1969 Mar; 27(3):239-48. PubMed ID: 5400246
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological properties of a series of derivatives of mefenamic and flufenamic acids].
    Linari G; Spanò R
    Farmaco Sci; 1971 Apr; 26(4):303-11. PubMed ID: 5559990
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral antipyretic therapy: evaluation of the N-aryl-anthranilic acid derivatives mefenamic acid, tolfenamic acid and flufenamic acid.
    Keinänen S; Similä S; Kouvalainen K
    Eur J Clin Pharmacol; 1978 Jul; 13(5):331-44. PubMed ID: 668793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind clinical study on long-term use of oxyphenbutazone and tolfenamic acid in connection with telecobalt therapy.
    Kauppila A; Vapaatalo H; Taskinen PJ
    Arzneimittelforschung; 1975 Jul; 25(7):1082-5. PubMed ID: 1101903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human metabolism of tolfenamic acid. II. Structure of metabolites and C-13 NMR assignments of fenamates.
    Khalifah RG; Hignite CE; Pentikäinen PJ; Penttilä A; Neuvonen PJ
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):269-76. PubMed ID: 7166179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The new anti-inflammatory acids. Niflumic acid in rheumatology].
    Camus JP
    Presse Med (1893); 1968 May; 76(22):1071-2. PubMed ID: 5300745
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-steroid anti-inflammatory agents.
    Br Med J; 1970 Aug; 3(5720):449-51. PubMed ID: 5454326
    [No Abstract]   [Full Text] [Related]  

  • 18. [New esters of N-arylanthranilic acids].
    Salimbeni A; Manghisi E; Magistretti MJ
    Farmaco Sci; 1975 Apr; 30(4):276-86. PubMed ID: 1183605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discussion on the pharmacology of the fenamates.
    Ann Phys Med; 1966; Suppl():70-6. PubMed ID: 6004861
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experimentation on a new analgesic with anti-inflammatory effect: N-(2,3-xylyl)-anthranilic acid].
    Barlattani M; Carignola W
    Clin Ter; 1969 Jun; 49(6):577-88. PubMed ID: 5386584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.